Semler Scientific, Inc. - Common Stock (SMLR)
28.78
+0.24 (0.84%)
NASDAQ · Last Trade: Sep 12th, 10:45 AM EDT
Detailed Quote
Previous Close | 28.54 |
---|---|
Open | 28.54 |
Bid | 28.78 |
Ask | 28.99 |
Day's Range | 28.40 - 28.95 |
52 Week Range | 21.77 - 81.56 |
Volume | 79,617 |
Market Cap | 209.12M |
PE Ratio (TTM) | 10.86 |
EPS (TTM) | 2.6 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 506,950 |
Chart
About Semler Scientific, Inc. - Common Stock (SMLR)
Semler Scientific is a healthcare technology company that specializes in developing innovative solutions to enhance the efficiency and accuracy of diagnostic and measurement processes in medical settings. The company focuses on creating proprietary products that allow healthcare providers to assess patients more effectively, particularly in relation to cardiovascular and respiratory health. By leveraging advanced technology and data analytics, Semler aims to improve patient outcomes and streamline interactions between healthcare professionals and patients, ultimately contributing to better overall healthcare delivery. Read More
News & Press Releases
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · September 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 11, 2025
NEW YORK - September 11, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. (NASDAQ: SMLR) of a class action securities lawsuit.
Via TheNewswire.com · September 11, 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · September 10, 2025
NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 10, 2025
NEW YORK - September 10, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. (NASDAQ: SMLR) of a class action securities lawsuit.
Via TheNewswire.com · September 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 9, 2025
NEW YORK - September 9, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Semler Scientific, Inc. (NASDAQ: SMLR) of a class action securities lawsuit.
Via TheNewswire.com · September 9, 2025
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Semler Scientific, Inc. (“Semler Scientific” or the “Company”) (NASDAQ: SMLR).
By Faruqi & Faruqi, LLP · Via Business Wire · September 9, 2025
Bitcoin (BTC) is currently navigating a pivotal phase in its market trajectory, with its price firmly entrenched around the $112,000 mark. This impressive valuation reflects a complex interplay of post-halving supply dynamics, unprecedented institutional demand, and a shifting global macroeconomic landscape. The cryptocurrency has not only demonstrated remarkable resilience
Via MarketMinute · September 8, 2025
The digital asset landscape is undergoing a monumental transformation in 2025, as an unprecedented wave of institutional capital sweeps into the cryptocurrency market. At the forefront of this financial revolution are Spot Bitcoin Exchange-Traded Funds (ETFs), which have emerged as the primary conduit for traditional finance to access digital assets,
Via MarketMinute · September 8, 2025
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · September 8, 2025
SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets technology products and services that assist its customers in evaluating and treating chronic diseases.
By Robbins LLP · Via GlobeNewswire · September 8, 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Semler Scientific To Contact Him Directly To Discuss Their Options
By Faruqi & Faruqi LLP · Via GlobeNewswire · September 7, 2025
NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 7, 2025
NEW YORK, Sept. 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · September 6, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 6, 2025
NEW YORK, NY - September 6, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) on behalf of investors that purchased or otherwise acquired Semler securities between March 10, 2021 and April 15, 2025 (the “Class Period”).
Via TheNewswire.com · September 6, 2025
Glancy Prongay & Murray LLP reminds investors of the upcoming October 28, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Semler Scientific Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025, inclusive (the “Class Period”).
By Glancy Prongay & Murray LLP · Via Business Wire · September 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 5, 2025
NEW YORK, NY - September 5, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) on behalf of investors that purchased or otherwise acquired Semler securities between March 10, 2021 and April 15, 2025 (the “Class Period”).
Via TheNewswire.com · September 5, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · September 4, 2025
NEW YORK, NY - September 4, 2025 ( NEWMEDIAWIRE ) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Semler Scientific, Inc. (“Semler” or the “Company”) (NASDAQ: SMLR) on behalf of investors that purchased or otherwise acquired Semler securities between March 10, 2021 and April 15, 2025 (the “Class Period”).
Via TheNewswire.com · September 4, 2025
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · September 4, 2025